All filters
Abstracts
Influence Of Directly Acting Antiviral Drugs Therapy Of Hepatitis C On The Course Of HIV Infection In Patients With HIV And Hepatitis C Co-Infection
V. Khombak, N. Matsiyeuskaya
Reviews in Antiviral Therapy & Infectious Diseases 3, 2020
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Abstracts
Recurrent Visceral Leishmaniasis In Immunocompromised Patient With Liver Cirrhosis
I. Kubiliūtė
Reviews in Antiviral Therapy & Infectious Diseases 3, 2020
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Abstracts
Young Russian Women With HIV/HCV Co-Infection: Clinical Status And Effective Medical Care Options
E. Boeva
Reviews in Antiviral Therapy & Infectious Diseases 3, 2020
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Abstracts
Endoscopic Pathological Changes In HIV-Positive Patients With Low CD4+ T- Lymphocyte Values
C. M. Olariu
Reviews in Antiviral Therapy & Infectious Diseases 3, 2020
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Abstracts
Serum Lipid Profile In HIV-Infected Patients, Receiving Different Regimens Of ART
N. Matsiyeuskaya
Reviews in Antiviral Therapy & Infectious Diseases 3, 2020
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Abstracts
The Role Of Direct Antiviral Therapy With Paritaprevir/Ritonavir + Ombitasvir + Dasabuvir On Fibrosis In Patients With Chronic Hepatitis C And Advanced Fibrosis
C. M. Olariu
Reviews in Antiviral Therapy & Infectious Diseases 3, 2020
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Abstracts
Hepatotoxicity Among HIV-Positive Ukrainian Patients Receiving Different Regimens Of ART
A. Kiurdzhyieva
Reviews in Antiviral Therapy & Infectious Diseases 3, 2020
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
COVID-19, Me and Clinical Pharmacology - Dr. Andrea Calcagno
Presented at:
Liverpool Course 2020
Abstracts
An assessment of the effects of dolutegravir on gene expression and levonorgestrel clearance in human hepatocytes in vitro
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Cobicistat (COBI)-boosted Protease Inhibitors (PIs) plasma and intracellular (IC) pharmacokinetics (PK) in nicotine users
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Glecaprevir/pibrentasvir pharmacokinetics in HCV/HIV patients co-administered with antiretroviral drugs
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
The valproic acid – dolutegravir drug-drug interaction is based on displacement of protein binding and unlikely to be clinically relevant
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Valproic acid co-administration is not associated with lower non-dolutegravir antiretrovirals’ exposures
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Short-term intravenous proton pump inhibitors and histamine H2 antagonists do not negatively affect sustained virologic response in hepatitis C cirrhotic patients treated with ledipasvir or velpatasvir containing antiviral regimens: a case series
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
High incidence of drug-drug interactions with hepatitis C direct-acting antivirals in patients hospitalized during their treatment
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Effect of tenofovir and bacavir on dolutegravir transport in vitro and in vivo
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Review on drug interactions of ART and tuberculosis medications
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Abstracts
Comparison of relative bioavailability of pediatric triumeq and pediatric dolutegravir/lamivudine dispersible tablets to conventional film coated tablets in healthy adults
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Influence of SLCO1B1 polymorphisms on lopinavir plasma concentration in Serbian HIV/AIDS patients
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Sofosbuvir and 007 pharmacokinetics among persons with HCV and active drug use
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Tenofovir plasma concentrations in pregnant women: comparison of hepatitis B and HIV-infected patients
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
HBV infections among HIV-infected mothers on ART and their exposed infants in a tertiary hospital, Nairobi Kenya
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019
Abstracts
Model-based simulted 3TC exposure in HIV population by varying renal function
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019